HomeHealth articleshyperekplexiaWhat Is Hyperekplexia?

Hyperekplexia - Diagnosis and Treatment

Verified dataVerified data
0

4 min read

Share

Hyperekplexia is a rare neurological condition characterized by hypertonia and startled responses to tactile or acoustic stimuli. Read the article to know more.

Medically reviewed by

Dr. Veerabhadrudu Kuncham

Published At March 3, 2023
Reviewed AtMarch 3, 2023

Introduction

Hyperekplexia is a rare genetic disorder that affects both males and females and is most often present at birth. However, the disorder may not manifest itself until adolescence or adulthood in some people. In the United States, one in every 40,000 people suffers from hyperekplexia.

What Is Hyperekplexia?

The National organization of rare diseases (NORD) defines hyperekplexia (HPX) as a hereditary neurological disorder. The condition is considered uncommon. HPX can occur in utero, as well as in newborns and infants. Therefore, children and adults can both be affected by the disorder. HPX may also be known by other names, such as:

  • Familial startle disease.

  • Hereditary hyperekplexia.

  • Startle syndrome.

  • Stiff-baby syndrome.

People with HPX have a heightened startle response to loud noises or other unexpected stimuli. As a result, infants have hypertonia or increased muscle tone. Infants experience extreme muscle tension following a startle response and cannot move. In addition, some infants may stop breathing during an episode of rigidity, which can result in a potentially fatal situation.

Furthermore, rigidity can cause some people to collapse without losing consciousness. People suffering from HPX may exhibit gait abnormalities, overactive reflexes, and other signs and symptoms.

What Causes Hyperekplexia?

HPX affects both men and women. Although it is most commonly seen in newborns, it can appear later in life, like in adolescence or adulthood. Most HPX cases occur due to inheriting an autosomal dominant trait, which means that only one mutated gene from a parent is required to develop the condition.

GLRA1 gene mutations cause the majority of cases of hyperekplexia. The GLRA1 gene codes for one component of the glycine receptor protein, the alpha (α)1 subunit. When this protein binds to glycine, signaling between cells is inhibited. Mutations in the GLRA1 gene result in the production of a receptor unable to respond to glycine. As a result, glycine is unable to regulate signaling in the spinal cord and brainstem. If glycine production is reduced or receptors are damaged, nerve cells are unable to regulate their reactivity and, as a result, respond to stimuli exaggeratedly. Mutations in other genes cause the remaining cases of hyperekplexia.

An autosomal recessive pattern and a further mutation are other possible causes of HPX. A person with an autosomal recessive pattern inherits two mutated genes, one from each parent, and the parents may not exhibit any signs or symptoms of the disorder. The genetic variant arises spontaneously in the early stages of an individual's development with new mutations.

What Are The Symptoms Of Hyperekplexia?

Individuals' overall severity of the condition can vary greatly. Although symptoms persist into adulthood, they are most common in infants and children. The most common symptom of HPX is an exaggerated startle reaction in response to a sudden stimulus.

Examples of stimuli include sounds, an unexpected touch, a surprise movement such as a bump, and unexpected sightings of people or other objects. Once the response is activated, the person experiences rigidity or muscle stiffness and is likelier to fall. There is also a risk of injury because they cannot catch themselves and break the fall with their arms.

Other symptoms associated with HPX include:

  • The arching of the head accompanies the startle reaction.

  • Jerking movements following a startle reaction or when attempting to fall asleep.

  • Severe muscle tension is most likely noticed in infants.

  • Lack of movement or slower-than-normal movement of infants.

  • Overactive reflexes.

  • Intermittent apnea (pause in breathing).

  • Unsteady gait.

  • Dislocated hip at birth.

  • Inguinal hernia (bulging of a part of the soft tissue in the abdomen).

According to Genetics Home Reference, a division of the National Library of Medicine, in most people, with hyperekplexia, the symptoms subside by age one. However, this is not the same for everyone, and some older people will continue to have a hyper-reactive startle response, rigidity episodes, falls, and movements while sleeping. They can also experience overstimulation in crowds or noisy environments.

How Is Hyperekplexia Diagnosed?

If an infant has an overactive startle response, increased stiffness, or a decreased ability to engage in voluntary movements, the healthcare provider may suspect HPX. This diagnosis is frequently considered in the differential diagnosis of infants who present with spells suggestive of seizures. Because HPX is usually inherited, the doctor will examine the family's medical history for clues to possible genetic diseases. The clinical presentation of HPX may be used to make an initial diagnosis.

To confirm, the doctor may advise tests such as electromyography (EMG), which examines how well the body's nerves control the muscles, and electroencephalography (EEG), which analyses the electrical activity occurring in various parts of the brain.

Additionally, genetic testing can be used to confirm a diagnosis and aid in discovering the cause. Finally, because genetic testing is constantly evolving, new testing may emerge later in life to help clarify any concerns.

How Is Hyperekplexia Treated?

  • Treatments frequently aim to manage HPX symptoms, particularly the overactive startle response and muscle systems. Unfortunately, there is no cure for the condition. Anti-anxiety and anti-spastic medications such as Clonazepam and Diazepam, as well as Carbamazepine, Phenobarbital, and others, may be used.

  • As an adjunct therapy, physical or occupational therapy may alleviate symptoms and assess the need for assistive and adaptive equipment (strollers, walkers, seating, and positioning devices) to enhance one's quality of life. Cognitive behavioral therapy (CBT) can also help with anxiety reduction.

  • When an infant has significant breathing difficulties, the doctor may recommend using a breathing or heart rate monitor to keep an eye on the child. Parents may also choose to learn infant CPR (cardiopulmonary resuscitation) so that they can assist their child in the event of an emergency.

Conclusion:

Hyperekplexia is a rare neurological condition characterized by hypertonia and startled responses to tactile or acoustic stimuli. Any unexpected diagnosis can be frightening, especially when involving a rare neurological disease. Connecting with people with similar disorders and symptoms is also a way to cope and find support. Among these are epilepsy, generalized anxiety, and TIC disorders (like Tourette syndrome). Finally, the more understanding of the condition and the treatment options available, the more one can feel in control of their health.

Frequently Asked Questions

1.

How Is Hyperekplexia Treated?

Clonazepam, an anti-anxiety and anti-spasticity medication, is the most efficient treatment for hyperekplexia in both infants and adults. Carbamazepine, Phenobarbital, Diazepam, 5-Hydroxytryptophan, Phenytoin, Piracetam, and Sodium valproate are additional medications that might be used. Genetic counseling can provide valuable support and guidance to patients and their families. Anxiety reduction may benefit from additional treatment modalities like cognitive and physical therapy.

2.

What Are the Characteristics of Hyperekplexia in Children?

Hyperekplexia is a genetic disorder characterized by hypertonia (heightened muscle tone) and an amplified startle response to unexpected stimuli, particularly loud noises, in affected infants. Subsequent to the startle reflex, infants go through a brief period of extreme rigidity, during which their movement is restricted. In some cases, these rigid episodes can lead to a temporary cessation of breathing, which, if prolonged, can be life-threatening. Infants with hereditary hyperekplexia typically experience hypertonia consistently, except during sleep.

3.

Is Hyperekplexia Reversible?

The manifestations of hereditary hyperekplexia tend to diminish by the age of one. Although older individuals may retain a heightened sensitivity to startling stimuli and experience episodes of rigidity, potentially resulting in falls. They may also continue to exhibit hypnagogic myoclonus or muscle jerks during sleep. As individuals with this condition age, they may develop a reduced tolerance for crowded environments and loud noises. Those who have both hereditary hyperekplexia and epilepsy can expect to experience seizures throughout their lifetime.

4.

Is Hyperekplexia a Form of Epilepsy?

Hyperekplexia is not epilepsy, although they both involve abnormal reactions to stimuli. Epilepsy is characterized by recurrent seizures, whereas hyperekplexia primarily manifests as an exaggerated startle response. In rare cases, infants affected by hereditary hyperekplexia may encounter episodes of recurring seizures, also known as epilepsy.

5.

What Methods Can Be Used to Decrease a Baby’s Startle Reflex?

To reduce the baby's startle reflex, several strategies can be attempted. Swaddling the baby tightly in a blanket can create a feeling of security and minimize the sudden movements linked to the startle reflex. Providing gentle rocking, calming sounds, and dim lighting can contribute to a peaceful environment. Additionally, gradually introducing the baby to various stimuli can assist in desensitization and reduce the exaggerated startle response. However, seeking guidance from a pediatrician is recommended for personalized advice and assistance.

6.

When Does the Startle Reflex Begin?

The startle reflex emerges shortly after birth and is typically assessed by healthcare practitioners within the first hours of a baby's life. It generally persists for a few months. Although each baby develops at their own pace, many parents observe the peak of the startle reflex within the first month, followed by a gradual decline between two to four months, and complete disappearance by approximately six months.

7.

What Does the Nose Tapping Test Involve in Diagnosing Hyperekplexia?

The clinical diagnosis of hyperekplexia involves conducting a nose-tapping test. When the nose of a typical baby is tapped, it will generally result in a blink response or no response, and habituation to the stimulus will be observed. However, in the case of a baby with hyperekplexia, nose-tapping triggers exaggerated startle reactions and episodes of stiffness without habituation. This distinctive response pattern helps differentiate individuals with hyperekplexia from those without the condition.

8.

What Is the Historical Background of Hyperekplexia?

Hyperekplexia, also known as startle disease, has an intriguing historical background. In the 1950s, Dr. Kirsten K published the first description of this condition in a medical journal. Kristensen, a Danish neurologist. Dr. Kristensen initially observed a family in which several members displayed exaggerated startle responses, particularly in response to unexpected stimuli.

9.

Is Hyperekplexia a Neurogenetic Condition That Can Be Managed?

Hyperekplexia is a treatable neurogenetic disease, although there is no definitive cure. Treatment options primarily focus on managing the symptoms and reducing the frequency and severity of exaggerated startle responses. This may involve medication to regulate neurotransmitters and improve symptom control, along with supportive therapies and interventions tailored to the individual's needs.

10.

How Frequently Does Hyperekplexia Occur?

The incidence of hyperekplexia is relatively rare. On average, it is predicted to have an impact on 1 in 40,000 to 1 in 100,000 individuals worldwide. However, it is crucial to remember that the exact incidence may vary across different populations and geographical regions. Early diagnosis and proper management are crucial in providing optimal care for individuals with hyperekplexia. The global number of individuals diagnosed with hyperekplexia exceeds 150, although the precise prevalence of the condition remains uncertain.

11.

Who Is Affected by Hyperekplexia?

Hyperekplexia typically manifests from birth and can affect individuals of both genders. It can affect individuals of any age, from newborns to adults. However, symptoms often appear early in life, during infancy or early childhood. In some cases, the onset of the disorder may be delayed until adolescence or adulthood. It is important to note that hyperekplexia can have varying degrees of severity, and its impact on individuals can vary from mild to more significant in terms of motor control and daily functioning.

12.

Which Chromosome Is Impacted by Hyperekplexia?

Hyperekplexia is primarily inherited as an autosomal dominant trait, although autosomal recessive or X-linked inheritance patterns can also occur. Several genes, including GLRA1, SLC6A5, GLRB, GPHN, and ARHGEF9 (X-linked), have been associated with the condition. In most cases, individuals with hyperekplexia carry a mutation in either the GLRA1 or SLC6A5 gene, and the presence of the disorder is often observed in one of their affected parents. The genes involved in hyperekplexia play a role in the production of the glycine protein. 

13.

When Should Hyperekplexia Be Suspected?

Hyperekplexia may be suspected when an individual exhibits symptoms such as an exaggerated startle response to sudden stimuli, often accompanied by a temporary stiffness or rigidity of the body. These symptoms can manifest in infancy or early childhood. If there is a positive family history of hyperekplexia or if the individual has a known genetic mutation associated with the condition, it may raise suspicion of hyperekplexia. When these signs and risk factors are present, it is recommended to get a medical evaluation and consultation with a healthcare professional to confirm the diagnosis and determine appropriate management strategies.
Source Article IclonSourcesSource Article Arrow
Dr. Veerabhadrudu Kuncham
Dr. Veerabhadrudu Kuncham

Pediatrics

Tags:

hyperekplexia
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

hyperekplexia

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy